Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
1977 • 8,468 citations
Nonparametric Estimation from Incomplete Observations
1958 • 7,673 citations
Statistical Methods for Rates and Proportions, 2nd ed
1981 • 3,735 citations
Partial residuals for the proportional hazards regression model
1982 • 2,578 citations
The Statistical Analysis of Failure Time Data
1982 • 2,300 citations
SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
1989 • 627 citations
Magnetic-Susceptibility Measurement of Human Iron Stores
1982 • 374 citations
Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload
1977 • 335 citations
Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress
1974 • 331 citations
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major
1993 • 272 citations
Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major
1985 • 272 citations
Marrow Transplantation in Patients with Thalassemia Responsive to Iron Chelation Therapy
1993 • 238 citations
The Clinical Approach to Thalassaemia
1984 • 228 citations
Reassessment of the Use of Desferrioxamine B in Iron Overload
1976 • 187 citations
The effect of erythroid hyperplasia on iron balance
1988 • 169 citations
Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major
1990 • 165 citations
Growth and sexual maturation in thalassemia major
1985 • 162 citations
Treatment of Cooley's anemia [see comments]
1990 • 136 citations
Prolonged survival in patients with beta-thalassemia major treated with deferoxamine
1991 • 120 citations
Pulmonary Syndrome in Patients With Thalassemia Major Receiving Intravenous Deferoxamine Infusions
1990 • 112 citations
Iron Excretion in Thalassaemia Major After Administration of Chelating Agents
1962 • 99 citations
Insulin dependent diabetes in thalassaemia.
1988 • 84 citations
Depletion of excessive liver iron stores with desferrioxamine
1984 • 82 citations
Development of iron-chelating agents for clinical use [editorial; comment]
1992 • 76 citations
Vision and hearing during deferoxamine therapy
1990 • 69 citations
Noninvasive Methods for the Early Detection of Hereditary Hemochromatosisa
1988 • 37 citations
Sustained normalization of cardiac function by chelation therapy in thalassaemia major
1989 • 33 citations
10 Management of Cooley's anaemia
1993 • 14 citations